FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?
Paradigm has confirmed it will use a twice weekly dosage of 2mg/kg injectable pentosan polysulfate sodium in its Phase 3 trial.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DIV | Ann: Removal from Trading Status | 01/07/20 | 0 | 390 | |||
|
|||||||
DIV | Ann: Completion of Termination Payment | 30/06/20 | 0 | 280 | |||
|
|||||||
DIV | Ann: Suspension from Trading Status - UBS ETFs | 11/05/20 | 0 | 372 | |||
|
|||||||
DIV | Ann: Month end units on issue | 04/05/20 | 0 | 335 | |||
|
|||||||
DIV | Ann: Final Distribution Announcement for March 2020 | 02/04/20 | 0 | 356 | |||
|
|||||||
DIV | Ann: Month end units on issue | 02/04/20 | 0 | 343 | |||
|
|||||||
DIV | Ann: Estimated Distribution Announcement | 25/03/20 | 0 | 333 | |||
|
|||||||
DIV | Ann: Indicative Distribution Timetable Announcement | 08:44 | 0 | 373 | |||
|
See All Discussions